SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019550
Filing Date
2016-05-16
Accepted
2016-05-16 16:20:17
Documents
65
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-10q_20160331.htm 10-Q 1741496
2 EX-10.1 mcrb-ex101_534.htm EX-10.1 838526
3 EX-10.3 mcrb-ex103_260.htm EX-10.3 179284
4 EX-31.1 mcrb-ex311_6.htm EX-31.1 9220
5 EX-31.2 mcrb-ex312_9.htm EX-31.2 9211
6 EX-32.1 mcrb-ex321_8.htm EX-32.1 7617
7 EX-32.2 mcrb-ex322_7.htm EX-32.2 7632
  Complete submission text file 0001564590-16-019550.txt   7015236

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT mcrb-20160331.xml EX-101.INS 1394801
9 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20160331.xsd EX-101.SCH 40170
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20160331_cal.xml EX-101.CAL 37455
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20160331_def.xml EX-101.DEF 97530
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20160331_lab.xml EX-101.LAB 291888
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20160331_pre.xml EX-101.PRE 218049
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 161654133
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences